Adaptive Biotechnologies CorporationAdaptive Biotechnologies CorporationAdaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

No trades
See on Supercharts
Market capitalization
‪354.03 M‬USD
−1.56USD
‪−225.25 M‬USD
‪170.28 M‬USD
‪138.51 M‬
Beta (1Y)
2.84

About Adaptive Biotechnologies Corporation

CEO
Chad Robins
Headquarters
Seattle
Employees (FY)
709
Founded
2009
ISIN
US00650F1093
FIGI
BBG001J2PFF5
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ADPT is 2.34 USD — it has decreased by 4.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Adaptive Biotechnologies Corporation stocks are traded under the ticker ADPT.
Adaptive Biotechnologies Corporation is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ADPT stock is 5.51% volatile and has beta coefficient of 2.84. Check out the list of the most volatile stocks — is Adaptive Biotechnologies Corporation there?
One year price forecast for Adaptive Biotechnologies Corporation has a max estimate of 10.00 USD and a min estimate of 5.00 USD.
ADPT earnings for the last quarter are −0.35 USD whereas the estimation was −0.34 USD which accounts for −3.35% surprise. Estimated earnings for the next quarter are −0.33 USD. See more details about Adaptive Biotechnologies Corporation earnings.
Adaptive Biotechnologies Corporation revenue for the last quarter amounts to ‪37.92 M‬ USD despite the estimated figure of ‪42.96 M‬ USD. In the next quarter revenue is expected to reach ‪48.45 M‬ USD.
Yes, you can track Adaptive Biotechnologies Corporation financials in yearly and quarterly reports right on TradingView.
ADPT stock has fallen by 13.20% compared to the previous week, the month change is a 25.64% fall, over the last year Adaptive Biotechnologies Corporation has showed a 71.31% decrease.
ADPT net income for the last quarter is ‪−69.44 M‬ USD, while the quarter before that showed ‪−50.30 M‬ USD of net income which accounts for −38.05% change. Track more Adaptive Biotechnologies Corporation financial stats to get the full picture.
Today Adaptive Biotechnologies Corporation has the market capitalization of ‪354.02 M‬, it has decreased by 5.03% over the last week.
No, ADPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ADPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adaptive Biotechnologies Corporation stock right from TradingView charts — choose your broker and connect to your account.
ADPT reached its all-time high on Jan 19, 2021 with the price of 71.25 USD, and its all-time low was 2.53 USD and was reached on Apr 11, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 709.00 employees. See our rating of the largest employees — is Adaptive Biotechnologies Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Adaptive Biotechnologies Corporation technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Adaptive Biotechnologies Corporation stock shows the sell signal. See more of Adaptive Biotechnologies Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Adaptive Biotechnologies Corporation future price: according to them, ADPT price has a max estimate of 10.00 USD and a min estimate of 5.00 USD. Read a more detailed Adaptive Biotechnologies Corporation forecast: see what analysts think of Adaptive Biotechnologies Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Adaptive Biotechnologies Corporation EBITDA is ‪−173.88 M‬ USD, and current EBITDA margin is −105.34%. See more stats in Adaptive Biotechnologies Corporation financial statements.